Navigation

Investiment.io
Financial analysis platform

Pfizer Inc.

PFE โ€ข NYSE

$28.91
โ–ฒ0.02 (0.05%)โ€ข REGULAR

Pfizer Inc.

$28.91
โ–ฒ0.1%
๐Ÿ“ŠSummary๐Ÿ“‹SEC Filings๐Ÿ‘ฅInsider Trading
๐Ÿ’ง

Cash Flow StatementPFE

Cash Flow Summary

Key cash flow metrics and liquidity indicators for PFE

๐Ÿ”„
Operating Cash Flow
$11,704,000
(in thousands)
๐Ÿ’ฐ
Free Cash Flow
$9,075,000
(in thousands)
๐Ÿ—๏ธ
Capital Expenditures
-$2,629,000
(in thousands)
๐Ÿ“ˆ
Net Change in Cash
$91,000
(in thousands)

Cash Flow Analysis

Analyze operating, investing, and financing cash flows over time

Period:annual

Select Metrics to Compare (4 selected)

Net Operating Cash Flow Trend & Growth

Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025$0.00K$8.50B$17.00B$25.50B$34.00B-80%-40%0%+40%+80%
  • Net Operating Cash Flow
  • Net Operating Cash Flow YoY Growth

Free Cash Flow Trend & Growth

Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025$0.00K$7.50B$15.00B$22.50B$30.00B-110%-55%0%+55%+110%
  • Free Cash Flow
  • Free Cash Flow YoY Growth

Capital Expenditures Trend & Growth

Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025$-4.00B$-3.60B$-3.20B$-2.80B$-2.40B-30%-15%0%+15%+30%
  • Capital Expenditures
  • Capital Expenditures YoY Growth

Net Change in Cash Trend & Growth

Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025$-3.00B$-1.50B$0.00K$1.50B$3.00B-1200%-800%-400%0%+400%
  • Net Change in Cash
  • Net Change in Cash YoY Growth